+7.0% Growth in Group Sales, +9.4% Growth in Volume Sold Strong Dynamics in Strategic Targeted Therapeutic Areas: +12.8% Solid Growth Outside the Five Major Western European Countries: +20.7%
+7.0% Growth in Group Sales, +9.4% Growth in Volume Sold Strong Dynamics in Strategic Targeted Therapeutic Areas: +12.8% Solid Growth Outside the Five Major Western European Countries: +20.7%
